We are live on
!
Find out more
ACM
Armbruster Capital Management Portfolio holdings
AUM
$671M
1-Year Est. Return
24.78%
This Fund
S&P 500
This Quarter
Est. Return
+11.58%
1 Year Est. Return
+24.78%
3 Year Est. Return
+64.34%
5 Year Est. Return
+57.58%
10 Year Est. Return
+177.91%
AUM
$386M
AUM Growth
+$35.2M
(+10%)
Cap. Flow
-$4.59M
Cap. Flow
% of AUM
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
59.59%
Holding
108
New
3
Increased
30
Reduced
37
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.53M |
| 2 |
Vanguard US Quality Factor ETF
VFQY
|
+$1.13M |
| 3 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$903K |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$737K |
| 5 |
Invesco S&P International Developed Low Volatility ETF
IDLV
|
+$614K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Small-Cap Value ETF
VBR
|
+$1.08M |
| 2 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$1.06M |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$958K |
| 4 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$852K |
| 5 |
Vanguard Mid-Cap Value ETF
VOE
|
+$849K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.82% |
| 2 | Healthcare | 1.07% |
| 3 | Consumer Staples | 0.85% |
| 4 | Financials | 0.6% |
| 5 | Energy | 0.59% |
Similar funds
LCM
TGCMU
SBFM
SP
AO
REST
CHCM
CCM
Armbruster Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Armbruster Capital Management held 108 positions worth $386M, up 10% from $351M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armbruster Capital Management's Q4 2022 filing shows 3 new, 30 increased, 37 reduced and 5 closed positions. Its largest new stake was AbbVie: 1,410 shares worth $228K. The largest sale was Vanguard Small-Cap Value ETF, an estimated $1.08M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, down from 1.9% a quarter earlier, followed by Healthcare and Consumer Staples.
- Armbruster Capital Management's largest Q4 2022 buy was AbbVie: 1,410 shares worth $228K.
- Armbruster Capital Management added most to iShares Core MSCI Emerging Markets ETF in Q4 2022, an estimated $1.53M increase.
- Armbruster Capital Management's biggest Q4 2022 reduction was Vanguard Small-Cap Value ETF, cutting an estimated $1.08M.
- Armbruster Capital Management fully exited Vanguard Tax-Exempt Bond Index Fund in Q4 2022, selling an estimated $852K.
- Armbruster Capital Management's ten largest holdings make up 60% of its $386M portfolio in Q4 2022.
- Armbruster Capital Management opened 3 new positions and closed 5 in Q4 2022.
- Armbruster Capital Management's portfolio value rose 10% quarter-over-quarter to $386M.
Based on Armbruster Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.